WebMD tackles childhood obesity with new websites

Share this article:
WebMD tackles childhood obesity with new websites
WebMD tackles childhood obesity with new websites
WebMD is expanding its wellness and prevention offering with several children's fitness sites aimed at besting childhood obesity.

The sites – Fit Junior, for ages 2-7, Fit Kids, for ages 8-12, and Fit Teens, for ages 13-19, along with a site for parents called Raising Fit Kids – are WebMD's first for kids, and come as part of an educational partnership with Sanford Health, a top non-profit rural healthcare provider and a leader in children's medical research. The sites will offer personalized resources and support to help promote and maintain a healthy lifestyle for kids based on “the four factors of healthy living: food, mood, recharge and move.”
On the professional side, Medscape will offer resources aimed at helping physicians combat childhood obesity among their patients.

The publisher doesn't yet have advertisers lined up for the sites but is in talks with “several large corporate sponsors,” a spokesperson said.
“We are committed to improving the health of children and their families across all health and wellness issues and we can't think of anything more important than the prevention of childhood obesity,” said CEO Wayne Gattinella.

According to Centers for Disease Control data, childhood obesity now affects 17% of children and adolescents in the US – triple the rate from just a generation ago – and one in seven preschool-aged low-income kids.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

More in News

Judge blocks FDA bid to allow generic Precedex

Judge blocks FDA bid to allow generic Precedex

The US District Court for Maryland granted Hospira a temporary restraining order (TRO) against FDA, after the agency determined that potential generic competitors of the company's injectable sedation drug Precedex ...

GSK drug gets aplastic anemia indication

GSK drug gets aplastic anemia indication

Promacta was previously indicated for chronic immune thrombocytopenia.

Five things for Pharma Marketers to know: Wednesday, August 27

Five things for Pharma Marketers to know: Wednesday, ...

Allergan sets a shareholder voting date, Novo describes the types of acquisitions it will consider, and the AstraZeneca-Pfizer talks can now reopen.